Location: New York, NY
CIK: 0001609251 · Show all filings
Period: Q3 2017 (← Previous) (Next →)
Filing Date: Nov 14, 2017
Total Value: $321M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ENTA | ENANTA PHARMACEUTICALS INC | 1,013,847 | $47.45M | 14.8% | $35.70 | +12.6% | COM | 29251M106 |
| GILD | GILEAD SCIENCES INC | 520,924 | $42.2M | 13.2% | $52.64 | +6.3% | COM | 375558103 |
| UTHR | UNITED THERAPEUTICS CORP | 346,511 | $40.61M | 12.7% | $133.07 | -4.0% | COM | 91307C102 |
| — | BIOVERATIV INC | 629,540 | $35.93M | 11.2% | $54.46 | — | COM | 97075E100 |
| — | SUCAMPO PHARMACEUTICALS-CL A | 2,833,416 | $33.43M | 10.4% | $11.89 | — | COM | 864909106 |
| MRK | MERCK & CO. INC. | 383,615 | $24.56M | 7.7% | $41.59 | +12.3% | COM | 58933Y105 |
| OM2 | ORTHOFIX INTERNATIONAL NV | 487,101 | $23.02M | 7.2% | $32.47 | — | COM | N6748L102 |
| — | HALYARD HEALTH INC | 478,621 | $21.55M | 6.7% | $40.65 | — | COM | 40650V100 |
| — | RTI SURGICAL INC | 4,413,821 | $20.08M | 6.3% | $4.39 | — | COM | 74975N105 |
| — | INVACARE CORP | 1,124,528 | $17.71M | 5.5% | $13.92 | — | COM | 461203101 |
| CNMD | CONMED CORP | 191,601 | $10.05M | 3.1% | $38.10 | +21.7% | COM | 207410101 |
| — | AVIRAGEN THERAPEUTICS INC | 2,836,326 | $1.943M | 0.6% | $1.21 | — | COM | 053761102 |
| — | DIGIRAD CORP | 334,179 | $1.153M | 0.4% | $4.41 | — | COM | 253827109 |
| — | JUNIPER PHARMACEUTICALS INC | 243,128 | $1.106M | 0.3% | $9.19 | — | COM | 48203L107 |